Sonic Healthcare Ltd
SHL: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$53.00 | Wmglnvz | Drhdzgbj |
Sonic Healthcare Earnings: Pathology Margins Weak but Set to Recover
Narrow-moat Sonic Healthcare's first-half group revenue grew 5% to AUD 4.3 billion, driven by acquisitions and strong organic performance in Australia and Germany. However, EBITDA fell 20% to AUD 737 million. This was largely due to higher-margin coronavirus revenue falling 90%, wage inflation, and Sonic still removing legacy coronavirus-related labor and infrastructure costs.